NASDAQ:OPRX OptimizeRx (OPRX) Earnings Date, Estimates & Call Transcripts $14.61 +0.38 (+2.67%) (As of 03:03 PM ET) Add Compare Share Share Today's Range$14.02▼$14.7250-Day Range$11.63▼$15.6352-Week Range$11.59▼$30.82Volume79,646 shsAverage Volume211,567 shsMarket Capitalization$250.27 millionP/E RatioN/ADividend YieldN/APrice Target$21.00 EarningsProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Earnings SummarySkip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueOPRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.OPRX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.OptimizeRx Analyst ForecastsQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20231($0.14)($0.14)($0.14) Q2 20231($0.24)($0.24)($0.24) Q3 20231$0.20$0.20$0.20 Q4 20231$0.01$0.01$0.01 FY 20234($0.17)($0.17)($0.17) Q1 20241($0.36)($0.36)($0.36) Q2 20241($0.24)($0.24)($0.24) Q3 20241($0.18)($0.18)($0.18) Q4 20241$0.04$0.04$0.04 FY 20244($0.74)($0.74) ($0.74) Get OptimizeRx Earnings AlertsEnter your email address below to receive the latest news and earnings results for OPRX and its competitors with MarketBeat's FREE daily newsletter. OPRX Earnings Date and InformationOptimizeRx last released its earnings results on March 8th, 2023. The reported $0.01 earnings per share (EPS) for the quarter. The company had revenue of $19.70 million for the quarter, compared to the consensus estimate of $21.84 million. OptimizeRx has generated ($0.79) earnings per share over the last year (($0.79) diluted earnings per share). Earnings for OptimizeRx are expected to grow in the coming year, from ($0.81) to ($0.74) per share. OptimizeRx has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 8th, 2023 based off prior year's report dates.Read More OptimizeRx Earnings History by Quarter Export to ExcelDateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/8/2023(Estimated) 5/10/2023Q1 2023($0.32)($0.34)($0.02)($0.31)$12.37 million$13.00 million3/8/2023Q4 2022$0.01+$0.01$0.04$21.84 million$19.70 million11/8/2022Q3 2022($0.18)($0.16)+$0.02($0.13)$15.16 million$15.09 million8/9/2022Q2 2022($0.09)($0.18)($0.09)($0.15)$17.10 million$13.98 million5/4/2022Q1 2022($0.08)($0.18)($0.10)($0.15)$13.78 million$13.73 million 2/24/2022Q4 2021$0.09$0.03($0.06)$0.03$20.09 million$20.30 million 11/9/20219/30/2021$0.13$0.09($0.04)$14.82 million$16.13 million 8/4/20216/30/2021$0.02$0.10+$0.08$0.02$12.35 million$13.63 million 5/6/2021Q1 2021($0.03)($0.01)+$0.02($0.06)$10.32 million$11.23 million2/23/202112/31/2020$0.16$0.16$0.14$16.02 million$16.43 million 11/9/2020Q3 2020($0.02)($0.01)+$0.01$10.04 million$10.52 million 8/5/20206/30/2020($0.03)$0.02+$0.05($0.07)$8.02 million$8.78 million 5/4/20203/31/2020($0.03)($0.06)($0.03)($0.15)$7.10 million$7.59 million 2/27/2020Q4 2019($0.05)($0.03)+$0.02($0.06)$7.66 million$7.38 million 11/5/2019Q3$0.04($0.11)($0.15)($0.11)$7.21 million$5.00 million 8/7/2019Q2 2019$0.03$0.03$0.03$6.78 million$7.01 million11/5/2018Q3 2018$0.01$0.02+$0.01$0.02$5.28 million$5.42 million11/5/2018Q3$0.01$0.02+$0.01$0.02$5.28 million$5.42 million8/7/2018Q2 2018($0.02)$0.02+$0.04$0.02$4.34 million$5.10 million8/7/2018Q2 2018$0.02$0.02$0.02$4.34 million$5.10 million5/2/2018Q1 2018($0.03)($0.03)($0.03)$4.11 million5/2/2018Q1 2018($0.03)($0.03)($0.03)$4.11 million2/27/2018Q4 2017($0.03)($0.03)($0.03)$4.01 million2/27/2018Q4 2017($0.01)($0.01)($0.01)$4.01 million11/2/2017Q3 2017($0.06)($0.06)($0.06)$3.10 million11/2/2017Q3 2017($0.02)($0.02)($0.02)$3.10 million8/1/2017Q2 2017($0.03)($0.03)($0.03)$2.87 million8/1/2017Q2 2017($0.01)($0.01)($0.01)$2.87 million 5/3/2017Q1 2017($0.09)($0.09)($0.09)$2.15 million5/3/2017Q1 2017($0.03)($0.03)($0.03)$2.15 million 3/8/2017Q4 2016($0.03)($0.03)($0.03)$2.29 million3/8/2017Q4 2016($0.01)($0.01)($0.01)$2.29 million11/7/2016Q3 2016($0.03)($0.03)($0.03)$1.79 million11/7/2016Q3 2016($0.01)($0.01)($0.01)$1.79 million8/8/2016Q2 2016($0.06)($0.06)($0.06)$2.05 million$1.91 million8/8/2016Q2 2016($0.02)($0.02)($0.02)$2.05 million$1.91 million5/9/2016Q1 2016($0.09)($0.03)+$0.06($0.03)$1.70 million$1.76 million5/9/2016Q1 2016($0.09)($0.03)+$0.06($0.03)$1.70 million$1.76 million3/15/2016Q4 2015($0.03)($0.03)($0.03)$2.30 million$2.02 million3/15/2016Q4 2015($0.03)($0.03)($0.03)$2.30 million$2.02 million8/11/2015Q2 2015($0.03)($0.03)($0.03)$1.92 million$1.71 million8/11/2015Q2 2015($0.01)($0.01)($0.01)$1.92 million$1.71 million3/31/2015Q4 2014$0.03$0.03$0.03$1.92 million$1.97 million3/31/2015Q4 2014$0.03$0.03$0.03$1.92 million$1.97 million11/13/2014Q3 2014($0.06)($0.06)($0.06)$1.71 million$1.62 million11/13/2014Q3 2014($0.06)($0.06)($0.06)$1.71 million$1.62 million 5/16/2014Q1 2014$0.03($0.12)($0.15)($0.12)$1.92 million$1.32 million5/16/2014Q1 2014$0.03($0.12)($0.15)($0.12)$1.92 million$1.32 million8/12/2013Q2 2013$0.06$0.03($0.03)$0.03$1.10 million$1.10 million8/12/2013Q2 2013$0.02$0.01($0.01)$0.01$1.10 million$1.10 million3/12/2013Q4 2012$0.01$0.01$0.015/15/2012Q1 2012($0.03)($0.02)+$0.01($0.02)OptimizeRx Earnings - Frequently Asked Questions When is OptimizeRx's earnings date? OptimizeRx has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 8th, 2023 based off last year's report dates. Learn more on OPRX's earnings history. How much revenue does OptimizeRx generate each year? OptimizeRx (NASDAQ:OPRX) has a recorded annual revenue of $62.45 million. How much profit does OptimizeRx generate each year? OptimizeRx (NASDAQ:OPRX) has a recorded net income of -$11.44 million. OPRX has generated -$0.79 earnings per share over the last four quarters. What is OptimizeRx's EPS forecast for next year? OptimizeRx's earnings are expected to grow from ($0.81) per share to ($0.74) per share in the next year. More Earnings Resources from MarketBeat Related Companies: DHX Earnings Results EGIO Earnings Results ZFOX Earnings Results MCHX Earnings Results UXIN Earnings Results RMNI Earnings Results GRVY Earnings Results QNST Earnings Results CASS Earnings Results ZH Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Nordstrom's Earnings Beat, A Rally In The MakingMacy's Stock Earnings, A Pivotal StoryC3.AI's Lukewarm Earnings: Failing to Cash in on AI Boom?NetApp Is Gearing Up To Breakout After Earnings Top EstimatesWhat U-Haul Earnings Are Showing, Heading Up?Can Earnings Narrow The Value Gap In Hewlett Packard?3 Late-Season Earnings Plays for Mid-Cap Traders This page (NASDAQ:OPRX) was last updated on 6/2/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OptimizeRx Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.